Raymond James & Associates’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
CIP
ICOM
Raymond James & Associates's LDL Position: Q1 2018 in Review
Raymond James & Associates sold out of Lydall, Inc. (LDL) in Q1 2018, closing a stake of 4,187 shares — an estimated $212K sold.
Raymond James & Associates first reported a position in LDL in Q2 2017 and held it in 3 quarters. The position peaked at $234K in Q3 2017. 157 funds tracked by Wall St. Rank hold LDL as of Q1 2018.
- Raymond James & Associates reported no remaining Lydall, Inc. position as of Q1 2018 after selling out during the quarter.
- Raymond James & Associates sold 4,187 Lydall, Inc. shares in Q1 2018, an estimated $212K.
- Raymond James & Associates first reported a position in Lydall, Inc. in Q2 2017 and held it in 3 quarters.
- Raymond James & Associates's Lydall, Inc. position peaked at $234K in Q3 2017.
- 157 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2018.
Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.